This change frees researchers to study cannabis products that most consumers encounter when buying medical marijuana – which could accelerate its treatment potential.
A cannabis legalization movement that for a decade rode a wave of success has stalled amid failed ballot initiatives, rising health concerns and a frayed coalition of supporters.
Researchers are anxiously awaiting government action on rescheduling cannabis.
Psilocybin falls into a regulatory gray zone, with strict limitations around how it can be studied. As a result, very little is known about its health risks, despite its surging popularity.
Chances for legalizing marijuana improved on Thursday with the NH Senate approving a bill that would allow possession of the drug and its sale…